One Cancer Start-Up’s Resolve To Crack The Mystery Of Metastasis
An Interview With Rgenix Co-Founders Masoud and Sohail Tavazoie
Rgenix, a New York-based start-up co-founded by three prominent physician researchers, is taking aim at what it contends is the future of cancer treatment: finding drugs that shut off the biological chain reaction called tumor metastasis – the colonization of malignant cells throughout the body that ends up killing the majority of cancer patients.
